Showing 291-300 of 7266 results for "".
Medical Meets Cosmetic in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/medical-meets-cosmetic-in-dermatology/21550/The contrast between cosmetic and medical may appear sharp, but a sound approach to dermatology requires both balance and blend.Melanoma Rates Rising in Young Adults: Are UV Lamps to Blame?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-rates-rising-in-young-adults-are-uv-lamps-to-blame/21644/New data suggest that the rate of melanoma among individuals age 18 to 39 is on the increase, with poor UV protection strategies implicated.Making the Case for Probiotics in Psoriasis Care
https://practicaldermatology.com/topics/psoriasis/making-the-case-for-probiotics-in-psoriasis-care/23702/A literature review reveals much promise, little peril.Dr. Anderson on New Tech That ‘Could be Revolutionary’ at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-anderson-on-new-tech-that-could-be-revolutionary-at-maui-derm/32921/In-vivo microscopy that will change how dermatologists practice and potentially revolutionary drug delivery systems were among the technologies highlighted by R. Rox Anderson, MD, PhD, during “Innovation in Dermatology 2025: A Look Into the Future of Dermatology” at the Maui Derm Hawaii 2025 meetingLook to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.'Combination Is Back,' Doctor Declares at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/combination-is-back-doctor-declares-at-maui-derm/32918/One of the most important studies of the past few years for dermatologists involved patients with ulcerative colitis, according to Arthur Kavanaugh, MD.Novel PsO Drug Could Be 'Closest Perception of a Cure,' Dr. Strober Says at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/novel-pso-drug-could-be-closest-perception-of-a-cure-dr-strober-says-at-maui-derm/32922/A novel monoclonal antibody targeting IL-23 for the treatment of psoriasis offers an extended half-life that will be a key differentiator for patients, according to Bruce Strober, MD, PhD.Assessing the Need for Re-Excision in Mild to Moderate Dysplastic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-the-need-for-re-excision-in-mild-to-moderate-dysplastic-nevi/21247/Re-excision may not be clinically warranted in a majority of cases.